Feature | Contrast Media | June 04, 2015

First U.S. Lumason Echocardiography Imaging Procedure Performed

Contrast agent indicated to opacify left ventricular chamber in suboptimal echocardiograms

Bracco, Lumason, first U.S. echocardiography procedure, Morristown

June 4, 2015 - Bracco Imaging announced that the first echocardiography imaging procedure with Lumason was performed in May at Morristown Medical Center, part of the Atlantic Health System, in New Jersey. This is the first administration after the development of the agent (sulfur hexafluoride lipid-type A microspheres) in the United States and approval by the U.S. Food and Drug Administration. The announcement was made through Bracco Imaging's affiliate Bracco Diagnostics Inc.

 "We're thrilled to be the first medical center to use Lumason in adults with suboptimal echocardiograms," said Linda Gillam, M.D., MPH, FASE, chair of the Gagnon Cardiovascular Institute at Morristown Medical Center. "Now we have an additional option when performing contrast enhanced ultrasound."

Lumason, internationally known as SonoVue in 40 countries, is an ultrasound contrast agent made up of gas-filled microbubbles (or microspheres) that reflect the sound waves to enhance the image.

Lumason has been approved by the FDA for use in adults with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.

The agent is supplied as a three-part kit. Each kit contains a Lumason vial containing 25 mg of lipid-type A lyophilized powder and 60.7 mg sulfur hexafluoride headspace, a prefilled syringe containing 5 mL of sodium chloride 0.9 percent injection, USP (Diluent), and a Mini-Spike.

For more information: www.braccoimaging.com

Related Content

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

The Philips Lumify point-of-care ultrasound (POCUS) system assessing a patient in the emergency room combined with telehealth to enable real-time collaboration with other physicians.

News | Coronavirus (COVID-19) | May 26, 2020
May 26, 2020  — Philips Healthcare recently received 510(k) clearance from the U.S.
An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020
May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University

News | Magnetic Resonance Imaging (MRI) | May 26, 2020
May 26, 2020 — Researchers from Tokyo Metropolitan...
Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 —Atrium Health is one of the first major health systems in the nation to put into wide practice a new...
Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

Richard J. Price, Ph.D., of the University of Virginia's School of Medicine and School of Engineering, is using focused soundwaves to overcome the natural 'blood-brain barrier,' which protects the brain from harmful pathogens. Photo courtesy of Dan Addison | UVA Communications

News | Focused Ultrasound Therapy | May 07, 2020
May 7, 2020 — University of Virginia researchers are pioneering the use of...
The new transducer reaches a 30% greater penetration, so clinicians have detailed images and performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps
News | Pediatric Imaging | May 06, 2020
May 6, 2020 — Philips announced the ...
Konica Minolta Healthcare's Rede Mini PACS are designed for specialty practices such as orthopedic, urgent care and family medicine clinics
News | PACS | April 28, 2020
April 28, 2020 – Konica Minolta Healthcare Americas released its Rede...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

News | Coronavirus (COVID-19) | April 24, 2020
April 24, 2020 — The Food and Drug Administration (FDA or the Agency) plays a critic